Bed Bath & Beyond Inc. (ticker: BBBY) shares are up more than 3.5 percent on Thursday after the company beat market expectations in its fiscal fourth quarter. But while the market is celebrating Bed Bath & Beyond’s surface-level numbers, some Wall Street analysts still see red flags.
Amazon.com, Inc. (AMZN) shares may be once again trading at all-time highs, but Wall Street analysts still love the tech giant as a long-term investment. But while most analysts focus on Amazon’s e-commerce and cloud services segments, Tigress Financial Partners analyst Ivan Feinseth believes Amazon’s fulfillment and shipping businesses could be a major piece of…
A new law signed by President Donald Trump this week repeals Federal Communications Commission restrictions that block internet providers from selling users’ internet browsing history to advertisers.
Fresh off the buzz from the company’s signature annual WrestleMania live event, World Wrestling Entertainment (ticker: WWE) stock is getting punched in the face this week.
Tesla Inc (ticker: TSLA) stock opened the week higher 5 percent after the company reported more than 25,000 vehicle deliveries in its first quarter.
General Electric Co. (GE) stock has lagged the Standard & Poor’s 500 index for more than a decade. But after years of frustration, GE investors may now be on the cusp of an extended period of outperformance.
Alphabet (ticker: GOOG, GOOGL) investors may not need to worry about the growing list of advertisers that are boycotting YouTube.
Akorn, Inc. AKRX 18.04% shares are up 18.2 percent on Friday after Bloomberg reported Frensius is considering a buyout bid for Akorn.
When a stock breaks out to new all-time highs, it can be difficult for technical traders to predict how much follow-through a breakout will have. Tesla Inc (NADAQ: TSLA) breached its 2014 all-time highs and eclipsed $300/share this week, breaking above a $290 resistance level that had held the stock down for nearly three years.
The U.S. Food and Drug Administration has issued a series of warnings about a handful of over-the-counter male sexual enhancement supplements. According to the FDA, laboratory analysis has identified that the following supplements contain a drug that could be life-threatening to certain users: